Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Jounce Therapeutics, Inc. (JNCE) since 2017 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Jounce Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1640455.
Total stock buying since 2017: $10,288,053.
Total stock sales since 2017: $38,172,624.
Total stock option exercises since 2017: $503,730.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 85,987 | $85,957 | 124,313 | $167,100 | 0 | $0 |
| 2022 | 0 | $0 | 68,167 | $469,192 | 0 | $0 |
| 2021 | 0 | $0 | 3,579,643 | $35,264,092 | 167,300 | $217,817 |
| 2020 | 0 | $0 | 70,268 | $531,755 | 10,000 | $42,100 |
| 2019 | 0 | $0 | 47,008 | $362,783 | 40,000 | $19,200 |
| 2018 | 1,900 | $14,896 | 58,292 | $1,377,702 | 121,092 | $224,613 |
| 2017 | 636,700 | $10,187,200 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-04 | 0 | $0 | 39,228 | $72,571 | 0 | $0 |
| 2023-03 | 85,987 | $85,957 | 0 | $0 | 0 | $0 |
| 2023-01 | 0 | $0 | 85,085 | $94,529 | 0 | $0 |
| 2022-01 | 0 | $0 | 68,167 | $469,192 | 0 | $0 |
| 2021-11 | 0 | $0 | 1,900,000 | $15,922,000 | 0 | $0 |
| 2021-04 | 0 | $0 | 200 | $2,000 | 0 | $0 |
| 2021-03 | 0 | $0 | 1,463,700 | $17,176,266 | 13,500 | $54,268 |
| 2021-02 | 0 | $0 | 200 | $2,356 | 0 | $0 |
| 2021-01 | 0 | $0 | 215,543 | $2,161,470 | 153,800 | $163,549 |
| 2020-11 | 0 | $0 | 30,000 | $213,855 | 0 | $0 |
| 2020-09 | 0 | $0 | 17,200 | $158,032 | 10,000 | $42,100 |
| 2020-08 | 0 | $0 | 6,546 | $30,834 | 0 | $0 |
| 2020-01 | 0 | $0 | 16,522 | $129,034 | 0 | $0 |
| 2019-12 | 0 | $0 | 40,000 | $334,799 | 40,000 | $19,200 |
| 2019-08 | 0 | $0 | 7,008 | $27,984 | 0 | $0 |
| 2018-09 | 0 | $0 | 0 | $0 | 32,000 | $15,360 |
| 2018-08 | 0 | $0 | 0 | $0 | 12,700 | $29,972 |
| 2018-06 | 1,900 | $14,896 | 0 | $0 | 24,875 | $99,997 |
| 2018-03 | 0 | $0 | 54,292 | $1,277,702 | 47,517 | $62,444 |
| 2018-01 | 0 | $0 | 4,000 | $100,000 | 4,000 | $16,840 |
| 2017-02 | 636,700 | $10,187,200 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-04-04 | Murray Richard /ca/ | Sale | 39,228 | 1.85 | 72,571 |
| 2023-03-14 | Tang Capital Partners Lp (10% Owner) | Buy | 20,286 | 1.02 | 20,651 |
| 2023-03-13 | Tang Capital Partners Lp (10% Owner) | Buy | 65,701 | .99 | 65,306 |
| 2023-01-10 | Trehu Elizabeth (Chief Medical Officer) | Sale | 5,126 | 1.12 | 5,741 |
| 2023-01-10 | Cole Hugh M (Chief Operating Officer) | Sale | 9,182 | 1.12 | 10,283 |
| 2023-01-10 | Drapkin Kimberlee C (CFO and Treasurer) | Sale | 7,781 | 1.12 | 8,714 |
| 2023-01-10 | Murray Richard /ca/ (CEO and President) | Sale | 24,879 | 1.12 | 27,864 |
| 2023-01-09 | Trehu Elizabeth (Chief Medical Officer) | Sale | 4,159 | 1.10 | 4,574 |
| 2023-01-09 | Cole Hugh M (Chief Operating Officer) | Sale | 7,452 | 1.10 | 8,197 |
| 2023-01-09 | Drapkin Kimberlee C (CFO and Treasurer) | Sale | 6,315 | 1.10 | 6,946 |
| 2023-01-09 | Murray Richard /ca/ (CEO and President) | Sale | 20,191 | 1.10 | 22,210 |
| 2022-01-10 | Trehu Elizabeth (Chief Medical Officer) | Sale | 5,378 | 6.65 | 35,763 |
| 2022-01-10 | Cole Hugh M (Chief Business Officer) | Sale | 6,205 | 6.65 | 41,263 |
| 2022-01-10 | Drapkin Kimberlee C (CFO and Treasurer) | Sale | 8,222 | 6.65 | 54,676 |
| 2022-01-10 | Murray Richard /ca/ (CEO and President) | Sale | 23,924 | 6.65 | 159,094 |
| 2022-01-07 | Trehu Elizabeth (Chief Medical Officer) | Sale | 3,005 | 7.30 | 21,936 |
| 2022-01-07 | Cole Hugh M (Chief Business Officer) | Sale | 3,468 | 7.30 | 25,316 |
| 2022-01-07 | Drapkin Kimberlee C (CFO and Treasurer) | Sale | 4,595 | 7.30 | 33,543 |
| 2022-01-07 | Murray Richard /ca/ (CEO and President) | Sale | 13,370 | 7.30 | 97,601 |
| 2021-11-12 | Levin Mark J (10% Owner) | Sale | 1,900,000 | 8.38 | 15,922,000 |
| 2021-04-15 | Higgons John Duncan | Sale | 200 | 10.00 | 2,000 |
| 2021-03-31 | Trehu Elizabeth (Chief Medical Officer) | Sale | 8,300 | 10.09 | 83,747 |
| 2021-03-31 | Trehu Elizabeth (Chief Medical Officer) | Option Ex | 8,300 | 4.02 | 33,366 |
| 2021-03-30 | Trehu Elizabeth (Chief Medical Officer) | Sale | 100 | 10.00 | 1,000 |
| 2021-03-30 | Trehu Elizabeth (Chief Medical Officer) | Option Ex | 100 | 4.02 | 401 |
| 2021-03-29 | Trehu Elizabeth (Chief Medical Officer) | Sale | 5,100 | 10.09 | 51,459 |
| 2021-03-29 | Trehu Elizabeth (Chief Medical Officer) | Option Ex | 5,100 | 4.02 | 20,501 |
| 2021-03-15 | Higgons John Duncan | Sale | 200 | 12.80 | 2,560 |
| 2021-03-01 | Levin Mark J (10% Owner) | Sale | 1,450,000 | 11.75 | 17,037,500 |
| 2021-02-16 | Higgons John Duncan | Sale | 200 | 11.78 | 2,356 |
| 2021-01-22 | Cole Hugh M (Chief Business Officer) | Sale | 18,000 | 11.95 | 215,100 |
| 2021-01-22 | Cole Hugh M (Chief Business Officer) | Option Ex | 10,000 | 5.47 | 54,750 |
| 2021-01-21 | Higgons John Duncan | Sale | 200 | 11.11 | 2,222 |
| 2021-01-21 | Drapkin Kimberlee C (CFO and Treasurer) | Sale | 3,799 | 12.00 | 45,588 |
| 2021-01-21 | Drapkin Kimberlee C (CFO and Treasurer) | Option Ex | 3,799 | 2.36 | 8,965 |
| 2021-01-21 | Murray Richard /ca/ (CEO and President) | Sale | 33,518 | 12.06 | 404,227 |
| 2021-01-21 | Murray Richard /ca/ (CEO and President) | Option Ex | 33,518 | .48 | 16,088 |
| 2021-01-20 | Trehu Elizabeth (Chief Medical Officer) | Sale | 6,500 | 12.01 | 78,065 |
| 2021-01-20 | Trehu Elizabeth (Chief Medical Officer) | Option Ex | 6,500 | 4.02 | 26,129 |
| 2021-01-20 | Higgons John Duncan | Sale | 1,500 | 12.00 | 18,000 |
| 2021-01-20 | Drapkin Kimberlee C (CFO and Treasurer) | Sale | 26,201 | 11.03 | 288,997 |
| 2021-01-20 | Drapkin Kimberlee C (CFO and Treasurer) | Option Ex | 13,501 | 1.19 | 16,106 |
| 2021-01-20 | Murray Richard /ca/ (CEO and President) | Sale | 16,482 | 12.04 | 198,443 |
| 2021-01-20 | Murray Richard /ca/ (CEO and President) | Option Ex | 16,482 | .48 | 7,911 |
| 2021-01-19 | Murray Richard /ca/ (CEO and President) | Sale | 40,000 | 9.59 | 383,600 |
| 2021-01-19 | Murray Richard /ca/ (CEO and President) | Option Ex | 40,000 | .48 | 19,200 |
| 2021-01-15 | Murray Richard /ca/ (CEO and President) | Sale | 30,000 | 8.54 | 256,199 |
| 2021-01-15 | Murray Richard /ca/ (CEO and President) | Option Ex | 30,000 | .48 | 14,400 |
| 2021-01-08 | Trehu Elizabeth (Chief Medical Officer) | Sale | 2,846 | 7.00 | 19,922 |
| 2021-01-08 | Cole Hugh M (Chief Business Officer) | Sale | 3,340 | 7.00 | 23,380 |
| 2021-01-08 | Drapkin Kimberlee C (CFO and Treasurer) | Sale | 3,130 | 7.00 | 21,910 |
| 2021-01-08 | Murray Richard /ca/ (CEO and President) | Sale | 11,816 | 7.00 | 82,712 |
| 2021-01-07 | Trehu Elizabeth (Chief Medical Officer) | Sale | 2,452 | 6.76 | 16,575 |
| 2021-01-07 | Cole Hugh M (Chief Business Officer) | Sale | 2,879 | 6.76 | 19,462 |
| 2021-01-07 | Drapkin Kimberlee C (CFO and Treasurer) | Sale | 2,697 | 6.76 | 18,231 |
| 2021-01-07 | Murray Richard /ca/ (CEO and President) | Sale | 10,183 | 6.76 | 68,837 |
| 2020-11-19 | Levin Mark J (10% Owner) | Sale | 15,000 | 7.00 | 105,075 |
| 2020-11-17 | Levin Mark J (10% Owner) | Sale | 15,000 | 7.25 | 108,780 |
| 2020-09-15 | Duncan Barbara Gayle | Sale | 10,000 | 10.00 | 100,000 |
| 2020-09-15 | Duncan Barbara Gayle | Option Ex | 10,000 | 4.21 | 42,100 |
| 2020-09-01 | Drapkin Kimberlee C (CFO and Treasurer) | Sale | 7,200 | 8.06 | 58,032 |
| 2020-08-18 | Cole Hugh M (Chief Business Officer) | Sale | 744 | 4.71 | 3,504 |
| 2020-08-18 | Drapkin Kimberlee C (CFO and Treasurer) | Sale | 744 | 4.71 | 3,504 |
| 2020-08-17 | Trehu Elizabeth (Chief Medical Officer) | Sale | 454 | 4.86 | 2,206 |
| 2020-08-17 | Cole Hugh M (Chief Business Officer) | Sale | 454 | 4.86 | 2,206 |
| 2020-08-17 | Drapkin Kimberlee C (CFO and Treasurer) | Sale | 454 | 4.86 | 2,206 |
| 2020-08-14 | Trehu Elizabeth (Chief Medical Officer) | Sale | 1,728 | 4.67 | 8,078 |
| 2020-08-14 | Cole Hugh M (Chief Business Officer) | Sale | 984 | 4.64 | 4,565 |
| 2020-08-14 | Drapkin Kimberlee C (CFO and Treasurer) | Sale | 984 | 4.64 | 4,565 |
| 2020-01-07 | Trehu Elizabeth (Chief Medical Officer) | Sale | 2,624 | 7.78 | 20,414 |
| 2020-01-07 | Cole Hugh M (Chief Business Officer) | Sale | 2,624 | 7.78 | 20,414 |
| 2020-01-07 | Drapkin Kimberlee C (CFO and Treasurer) | Sale | 2,624 | 7.78 | 20,414 |
| 2020-01-07 | Murray Richard /ca/ (CEO and President) | Sale | 7,150 | 7.78 | 55,627 |
| 2020-01-06 | Higgons John Duncan | Sale | 1,500 | 8.11 | 12,165 |
| 2019-12-23 | Murray Richard /ca/ (CEO and President) | Sale | 40,000 | 8.37 | 334,799 |
| 2019-12-23 | Murray Richard /ca/ (CEO and President) | Option Ex | 40,000 | .48 | 19,200 |
| 2019-08-16 | Trehu Elizabeth (Chief Medical Officer) | Sale | 1,018 | 3.92 | 3,990 |
| 2019-08-16 | Cole Hugh M (Chief Business Officer) | Sale | 1,018 | 3.92 | 3,990 |
| 2019-08-16 | Drapkin Kimberlee C (CFO and Treasurer) | Sale | 1,018 | 3.92 | 3,990 |
| 2019-08-15 | Trehu Elizabeth (Chief Medical Officer) | Sale | 648 | 4.00 | 2,592 |
| 2019-08-15 | Cole Hugh M (Chief Business Officer) | Sale | 648 | 4.00 | 2,592 |
| 2019-08-15 | Drapkin Kimberlee C (CFO and Treasurer) | Sale | 648 | 4.00 | 2,592 |
| 2019-08-14 | Trehu Elizabeth (Chief Medical Officer) | Sale | 670 | 4.10 | 2,746 |
| 2019-08-14 | Cole Hugh M (Chief Business Officer) | Sale | 670 | 4.10 | 2,746 |
| 2019-08-14 | Drapkin Kimberlee C (CFO and Treasurer) | Sale | 670 | 4.10 | 2,746 |
| 2018-09-06 | Murray Richard /ca/ (CEO and President) | Option Ex | 32,000 | .48 | 15,360 |
| 2018-08-27 | Drapkin Kimberlee C (CFO and Treasurer) | Option Ex | 12,700 | 2.36 | 29,972 |
| 2018-06-15 | Cole Hugh M (Chief Business Officer) | Buy | 1,900 | 7.84 | 14,896 |
| 2018-06-08 | Trehu Elizabeth (Chief Medical Officer) | Option Ex | 24,875 | 4.02 | 99,997 |
| 2018-03-15 | Duncan Barbara Gayle | Sale | 2,000 | 28.11 | 56,220 |
| 2018-03-15 | Duncan Barbara Gayle | Option Ex | 2,000 | 4.21 | 8,420 |
| 2018-03-08 | Trehu Elizabeth (Chief Medical Officer) | Sale | 4,545 | 25.06 | 113,897 |
| 2018-03-08 | Trehu Elizabeth (Chief Medical Officer) | Option Ex | 4,545 | 4.02 | 18,270 |
| 2018-03-08 | Drapkin Kimberlee C (CFO and Treasurer) | Sale | 5,267 | 25.01 | 131,727 |
| 2018-03-08 | Drapkin Kimberlee C (CFO and Treasurer) | Option Ex | 3,759 | .48 | 1,804 |
| 2018-03-08 | Murray Richard /ca/ (CEO and President) | Sale | 16,334 | 25.10 | 409,983 |
| 2018-03-08 | Murray Richard /ca/ (CEO and President) | Option Ex | 16,334 | .48 | 7,840 |
| 2018-03-05 | Trehu Elizabeth (Chief Medical Officer) | Sale | 4,545 | 21.68 | 98,512 |
| 2018-03-05 | Trehu Elizabeth (Chief Medical Officer) | Option Ex | 4,545 | 4.02 | 18,270 |
| 2018-03-05 | Drapkin Kimberlee C (CFO and Treasurer) | Sale | 5,267 | 21.64 | 113,977 |
| 2018-03-05 | Murray Richard /ca/ (CEO and President) | Sale | 16,334 | 21.64 | 353,386 |
| 2018-03-05 | Murray Richard /ca/ (CEO and President) | Option Ex | 16,334 | .48 | 7,840 |
| 2018-01-26 | Duncan Barbara Gayle | Sale | 4,000 | 25.00 | 100,000 |
| 2018-01-26 | Duncan Barbara Gayle | Option Ex | 4,000 | 4.21 | 16,840 |
| 2017-02-01 | Higgons John Duncan (Director) | Buy | 6,700 | 16.00 | 107,200 |
| 2017-02-01 | Karsen Perry A (Director) | Buy | 5,000 | 16.00 | 80,000 |
| 2017-02-01 | Celgene Corp /de/ (10% Owner) | Buy | 625,000 | 16.00 | 10,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of JNCE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Jounce Therapeutics, Inc. (symbol JNCE, CIK number 1640455) see the Securities and Exchange Commission (SEC) website.